Elsevier

Dermatologic Clinics

Volume 20, Issue 2, April 2002, Pages 347-355
Dermatologic Clinics

Current therapy
Management of pyoderma gangrenosum

https://doi.org/10.1016/S0733-8635(01)00029-8Get rights and content

Section snippets

Establishing the diagnosis

The diagnosis of PG may be difficult because of its protean morphologic manifestations. It is important to be aware of the clinical circumstances in which this disorder is likely to present. As with many other cutaneous disorders, establishing the diagnosis in PG requires:

  • 1.

    Recognition of the clinical features

  • 2.

    Performing a skin biopsy to reveal histologic findings consistent with PG

  • 3.

    Investigations to rule out other similar cutaneous eruptions.

The four main clinical types of PG are: Ulcerative,

Search for systemic disease

Categorising PG according to its predominant morphologic features is helpful as a guide to the possibility of underlying systemic disease. Thus, it has been shown in many series that the majority of patients (over 70%) with ulcerative PG will have an associated disease. Arthritis, inflammatory bowel disease, monoclonal gammopathy and internal malignancy are the most common associations [7]. As already outlined, eruptive pustular PG occurs almost exclusively in the setting of acute inflammatory

Stabilization of the patient

Patients who present to dermatologists with PG are often experiencing extremely painful and progressive destruction of their skin tissue. In many cases they have previously received inappropriate treatment which has proved to be of no benefit. They are usually frightened, insecure, and may have lost confidence in their medical care. Some may be experiencing adverse effects of previous therapies. Having established the diagnosis with as much certainty as possible, and while instigating the

Wound care

The principle guiding wound care in a patient with PG should be the avoidance of undue trauma or irritation of the wound surface, and the prevention of secondary infection. Local relief of pain using bland cleansing agents or topical steroids and the creation of a suitable milieu or environment to promote tissue growth with wound healing is important. In the initial evaluation of an ulcerative PG lesion it is important to document location, size, outline and depth as indicated earlier. Clinical

Topical and intralesional agents

Therapies used locally in the skin for lesions of PG are listed below:

  • Hyperbaric oxygen

  • Benzyl peroxide

  • Corticosteroids (topically/intralesional)

  • Disodium chromoglycate (topical)

  • Nicotine (topical)

  • Cyclosporin (intralesional)

  • Tacrolimus (topical/intralesional)

  • Macrophage colony stimulating factor (intralesional)

  • Human platelet-derived growth factor

  • Skin grafts

  • Cultured allografts/autografts

  • X-ray therapy

Local agents can be used in isolation in slowly progressive Vegetative PG lesions, or in combination

Systemic treatments

The majority of patients with PG will require systemic treatment to control their disease. This is particularly so in patients with either ulcerative or bullous PG. Patients with the explosive pustular variant of PG often show poor response to systemic treatment and require active intervention in the closely related acute inflammatory bowel disease to achieve control of their cutaneous lesions. Many patients with vegetative PG respond to local wound care, or require some of the milder systemic

Other approaches

Although it is important to have a logical and sequential approach to the management of a patient with PG, the unpredictable nature of this disease and its variation in aggressiveness in individual patients mean that a flexible approach must be adopted. Often more than one therapeutic agent will be required, and improvisation may be necessary if standard approaches fail to bring about satisfactory results. Thus treatments as diverse as plasma exchange, intestinal decontamination and Chinese

First page preview

First page preview
Click to open first page preview

References (32)

  • A.C. Ronnau et al.

    Pyoderma gangrenosum after cesarean delivery

    Am J Obstet Gynecol

    (2000)
  • F.C. Powell et al.

    Pyoderma gangrenosum: A review of 86 patients

    Quarterly J Med, New Series 55

    (1985)
  • H.O. Perry et al.

    Bullous pyoderma gangrenosum and leukaemia

    Arch Dermatol

    (1972)
  • Collins S., Carolan D., O'Loughlin S., Powell F.C. Prognostic indicators in pyoderma gangrenosum. A study of 31...
  • C.J. Dunwoody et al.

    Pyoderma gangrenosum: A case study for pain management in dermatology nursing

    Dermatology Nursing

    (2000)
  • V. Wasserteil et al.

    Pyoderma gangrenosum treated with hyperbaric oxygen therapy

    Int J Dermatol

    (1992)
  • Cited by (0)

    Bruce H. Thiers, MD, Consulting Editor

    View full text